Literature DB >> 10516476

Hepatitis C virus and hepatocarcinogenesis.

J Hayashi1, H Aoki, Y Arakawa, O Hino.   

Abstract

Although human hepatocellular carcinoma (HCC) is one of the most common types of tumors in the world, the molecular mechanisms underlying hepatitis-C-related human hepatocarcinogenesis are still not clear. HCC is accompanied by virus infections in most cases, and it is suggested that hepatitis B virus and hepatitis C virus (HCV) significantly influence the oncogenic process. The persistence of inflammation following HCV infection is reportedly related to carcinogenesis, and the mechanism of chronic inflammation has been approached by taking viral, immunologic, cytokine and apoptotic responses into consideration. With the progress made in molecular biology, the functional abnormality of oncogenes/tumor suppressor genes has been identified and, apart from the p53 gene, involvement of the IGF-II gene has also been described recently. Furthermore, it has been suggested that uncontrolled proliferation of cancer cells might be based on abnormal regulation of intracellular signal transduction pathways. Here we review the cutting edge of molecular hepatitis C virology in terms of virus-cell interactions, which may contribute to the development of human HCCs. We also discuss the recent progress made in the molecular and cell biology of human hepatocarcinogenesis.

Entities:  

Mesh:

Year:  1999        PMID: 10516476     DOI: 10.1159/000024962

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  9 in total

1.  p73 overexpression and nuclear accumulation in hepatitis C virus-associated hepatocellular carcinoma.

Authors:  Romy Zemel; Claud Koren; Larisa Bachmatove; Smadar Avigad; Ella Kaganovsky; Elimelech Okon; Ziv Ben-Ari; Franklin Grief; Merav Ben-Yehoyada; Yosef Shaul; Ran Tur-Kaspa
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

2.  First multicenter study for risk factors for hepatocellular carcinoma development in North Africa.

Authors:  Olfa Bahri; Sayeh Ezzikouri; Nissaf Ben Alaya-Bouafif; Fella Iguer; Abdallah Essaid El Feydi; Hafedh Mestiri; Moustapha Benazzouz; Tahar Khalfallah; Rajaa Afifi; Latifa Elkihal; Salah Berkane; Agnes Marchio; Nabil Debzi; Anne Dejean; Pascal Pineau; Hinda Triki; Soumaya Benjelloun
Journal:  World J Hepatol       Date:  2011-01-27

3.  Generation of infectious hepatitis C virus in immortalized human hepatocytes.

Authors:  Tatsuo Kanda; Arnab Basu; Robert Steele; Takaji Wakita; Jan S Ryerse; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Hepatitis C virus genotype 1a growth and induction of autophagy.

Authors:  Malika Ait-Goughoulte; Tatsuo Kanda; Keith Meyer; Jan S Ryerse; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

5.  Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients.

Authors:  Roberto Mazzanti; Luca Messerini; Camilla E Comin; Lorenzo Fedeli; Nathalie Ganne-Carrie; Michel Beaugrand
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

Review 6.  Targeting insulin-like growth factor axis in hepatocellular carcinoma.

Authors:  Jennifer Wu; Andrew X Zhu
Journal:  J Hematol Oncol       Date:  2011-07-05       Impact factor: 17.388

Review 7.  Small, Smaller, Nano: New Applications for Potato Virus X in Nanotechnology.

Authors:  Juliane Röder; Christina Dickmeis; Ulrich Commandeur
Journal:  Front Plant Sci       Date:  2019-02-19       Impact factor: 5.753

8.  Evaluation of a recombinant measles virus expressing hepatitis C virus envelope proteins by infection of human PBL-NOD/Scid/Jak3null mouse.

Authors:  Masaaki Satoh; Makoto Saito; Kohsuke Tanaka; Sumako Iwanaga; Salem Nagla Elwy Salem Ali; Takahiro Seki; Seiji Okada; Michinori Kohara; Shinji Harada; Chieko Kai; Kyoko Tsukiyama-Kohara
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2010-03-17       Impact factor: 2.268

9.  Production of Hybrid Chimeric PVX Particles Using a Combination of TMV and PVX-Based Expression Vectors.

Authors:  Christina Dickmeis; Mareike Michaela Antonia Honickel; Rainer Fischer; Ulrich Commandeur
Journal:  Front Bioeng Biotechnol       Date:  2015-11-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.